Press Releases from Hermes Medical Solutions

Hermes Medical Solutions, a global leader in molecular imaging and dosimetry software, announces the latest FDA cleared and CE-marked release of its flagship solution Hermia, featuring new capabilities designed to elevate precision, standardization, and efficiency in brain imaging.

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, receives 510(k) FDA Clearance for the new version of Hermia Voxel Dosimetry.

Hermes Medical Solutions (HMS), a global leader in molecular imaging and dosimetry software, announces the latest CE-marked release of its flagship platform, Hermia, featuring new capabilities designed to elevate precision, standardization, and efficiency in nuclear medicine.

Hermes Medical Solutions (HMS), a global leader in molecular imaging and dosimetry software solutions, proudly announces the latest updates within Hermia, including new CE marked functionalities*, designed to advance precision and efficiency in nuclear medicine imaging and dosimetry.

Hermes Medical Solutions is proud to announce its participation in the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium’s groundbreaking Precision Dosimetry Imaging Biomarker (PDIB) project. This ambitious international initiative seeks to transform radiopharmaceutical therapy (RPT) through improved dosimetry, leading to more effective and personalized cancer treatments.

In a testament to its global impact, the top hospitals recognized in Newsweek's World's Best Hospitals 2025 rankings have integrated Hermia, the all-in-one molecular imaging software suite from Hermes Medical Solutions, into their clinical practices. From leading institutions in the United States and to premier hospitals in Europe and beyond, Hermia has become an essential tool in delivering precise diagnostics and optimized patient care.